Bristol Myers Squibb : BMY

All Bristol Myers Squibb Articles

596 Articles

Paul Ausick | Oct 11, 2016 at 4:04 PM EDT

Bristol-Myers, Gilead Slide Into Tuesday’s 52-Week Low Club

October 11, 2016: Here are four stocks trading with relatively heavy volume among 69 equities making new 52-week lows in…

Paul Ausick | Oct 10, 2016 at 4:04 PM EDT

Bristol-Myers, Staples Fall Into Monday’s 52-Week Low Club

October 7, 2016: Here are four stocks trading with relatively heavy volume among 26 equities making new 52-week lows in…

Chris Lange | Oct 10, 2016 at 11:25 AM EDT

Monday’s 3 Major Biopharma Movers

On Monday morning, Merck, Mylan and Bristol-Myers Squibb made substantial runs, either up or down.

Paul Ausick | Oct 3, 2016 at 4:04 PM EDT

Wells Fargo, Bristol-Myers Drop in on Monday’s 52-Week Low Club

October 3, 2016: Here are four stocks trading with relatively heavy volume among 29 equities making new 52-week lows in…

Paul Ausick | Sep 28, 2016 at 4:04 PM EDT

Bristol-Myers, Abercrombie & Fitch Slide into Wednesday’s 52-Week Low Club

September 28, 2016: Here are four stocks trading with relatively heavy volume among 33 equities making new 52-week lows in…

Chris Lange | Sep 27, 2016 at 7:40 AM EDT

Major Pharma Continues to See Rising Tide in Short Interest

The September 15 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical…

Chris Lange | Sep 13, 2016 at 10:25 AM EDT

Jefferies Issues Top Pharma and Biohealth Stocks to Buy

Despite recent market headwinds and volatility, there are strong underlying fundamentals among the large cap pharmaceuticals that are continuing to…

Chris Lange | Sep 13, 2016 at 7:25 AM EDT

Major Pharma Continues to See Significant Drop in Short Interest

The August 31 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical…

Paul Ausick | Sep 12, 2016 at 4:04 PM EDT

Kroger, Whole Foods in Monday’s 52-Week Low Club

September 12, 2016: Here are four stocks trading with relatively heavy volume among 56 equities making new 52-week lows in…

Paul Ausick | Sep 2, 2016 at 4:04 PM EDT

Bristol-Myers, Verifone Dive into Friday’s 52-Week Low Club

September 2, 2016: Here are four stocks trading with relatively heavy volume among 21 equities making new 52-week lows in…

Chris Lange | Aug 25, 2016 at 8:45 AM EDT

Major Pharma Short Interest Faces Significant Drop

The August 15 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical…

Chris Lange | Aug 10, 2016 at 9:05 AM EDT

Major Pharma Short Interest Slides

The July 29 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical…

Jon C. Ogg | Aug 8, 2016 at 12:45 PM EDT

Why Credit Suisse Sees Merck and Bristol-Myers Gap Widening Further

Credit Suisse sees the Bristol-Myers Squibb gap with Merck getting even worse, even though it still has robust I-O franchise…

Jon C. Ogg | Aug 8, 2016 at 8:55 AM EDT

Top Analyst Upgrades and Downgrades: BlackRock, Bristol-Myers, Level 3, NVIDIA, Monsanto, 21st Century Fox and More

The top analyst upgrades, downgrades and initiations seen on Monday morning include BlackRock, Bristol-Myers, Level 3, NVIDIA, Monsanto and Twenty-First…

Chris Lange | Aug 5, 2016 at 10:35 AM EDT

Why Bristol-Myers Failure Is a Huge Win for Merck

Bristol-Myers Squibb shares took a nosedive early Friday's following an update in its late-stage Checkmate trial. But Bristol-Myer's failure was…

1 … 22 23 24 25 26 … 40

Bristol Myers Squibb : BMY

All Bristol Myers Squibb Articles

Bristol-Myers, Gilead Slide Into Tuesday’s 52-Week Low Club

Bristol-Myers, Staples Fall Into Monday’s 52-Week Low Club

Monday’s 3 Major Biopharma Movers

Wells Fargo, Bristol-Myers Drop in on Monday’s 52-Week Low Club

Bristol-Myers, Abercrombie & Fitch Slide into Wednesday’s 52-Week Low Club

Major Pharma Continues to See Rising Tide in Short Interest

Jefferies Issues Top Pharma and Biohealth Stocks to Buy

Major Pharma Continues to See Significant Drop in Short Interest

Kroger, Whole Foods in Monday’s 52-Week Low Club

Bristol-Myers, Verifone Dive into Friday’s 52-Week Low Club

Major Pharma Short Interest Faces Significant Drop

Major Pharma Short Interest Slides

Why Credit Suisse Sees Merck and Bristol-Myers Gap Widening Further

Top Analyst Upgrades and Downgrades: BlackRock, Bristol-Myers, Level 3, NVIDIA, Monsanto, 21st Century Fox and More

Why Bristol-Myers Failure Is a Huge Win for Merck

Illinois Offered Her $100,000 for Part of Her Pension COLA. The Raise She Gives Up Lasts the Rest of Her Life.

A $1.8 Million Portfolio, Two Withdrawal Plans: One Triggers IRMAA and RMD Taxes, One Never Does

Math Doesn’t Have Feelings: Dave Ramsey to a Debt-Free Caller Who Feels Like He Has Only $300 Left a Week on $105,000

Illinois Offered Her $100,000 for Part of Her Pension COLA. The Raise She Gives Up Lasts the Rest of Her Life.

A $1.8 Million Portfolio, Two Withdrawal Plans: One Triggers IRMAA and RMD Taxes, One Never Does

Illinois Offered Her $100,000 for Part of Her Pension COLA. The Raise She Gives Up Lasts the Rest of Her Life.

A $1.8 Million Portfolio, Two Withdrawal Plans: One Triggers IRMAA and RMD Taxes, One Never Does

Bristol Myers Squibb : BMY

All Bristol Myers Squibb Articles

Bristol-Myers, Gilead Slide Into Tuesday’s 52-Week Low Club

Bristol-Myers, Staples Fall Into Monday’s 52-Week Low Club

Monday’s 3 Major Biopharma Movers

Wells Fargo, Bristol-Myers Drop in on Monday’s 52-Week Low Club

Bristol-Myers, Abercrombie & Fitch Slide into Wednesday’s 52-Week Low Club

Major Pharma Continues to See Rising Tide in Short Interest

Jefferies Issues Top Pharma and Biohealth Stocks to Buy

Major Pharma Continues to See Significant Drop in Short Interest

Kroger, Whole Foods in Monday’s 52-Week Low Club

Bristol-Myers, Verifone Dive into Friday’s 52-Week Low Club

Major Pharma Short Interest Faces Significant Drop

Major Pharma Short Interest Slides

Why Credit Suisse Sees Merck and Bristol-Myers Gap Widening Further

Top Analyst Upgrades and Downgrades: BlackRock, Bristol-Myers, Level 3, NVIDIA, Monsanto, 21st Century Fox and More

Why Bristol-Myers Failure Is a Huge Win for Merck

Illinois Offered Her $100,000 for Part of Her Pension COLA. The Raise She Gives Up Lasts the Rest of Her Life.

A $1.8 Million Portfolio, Two Withdrawal Plans: One Triggers IRMAA and RMD Taxes, One Never Does

Math Doesn’t Have Feelings: Dave Ramsey to a Debt-Free Caller Who Feels Like He Has Only $300 Left a Week on $105,000

Featured Reads

Illinois Offered Her $100,000 for Part of Her Pension COLA. The Raise She Gives Up Lasts the Rest of Her Life.

A $1.8 Million Portfolio, Two Withdrawal Plans: One Triggers IRMAA and RMD Taxes, One Never Does